Skip to content

Comparison of efficacy of single-port suprapubic transvesical robotic assisted radical prostatectomy versus traditional robotic assisted radical prostatectomy

Comparison of efficacy of single-port suprapubic transvesical robotic assisted radical prostatectomy versus traditional robotic assisted radical prostatectomy

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100050050
Enrollment
Unknown
Registered
2021-08-16
Start date
2021-08-16
Completion date
Unknown
Last updated
2022-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate cancer

Interventions

single-port group:single-port suprapubic transvesical robotic assisted radical prostatectomy
traditional group:traditional robotic assisted radical prostatectomy

Sponsors

Zhongshan Hospital, Fudan University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
30 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged 30 to 90 years; 2. Patients with localized prostate cancer who received robot-assisted suprapubic transvesical single-port laparoscopic radical prostatectomy or robot-assisted laparoscopic radical prostatectomy; 3. Prostate biopsy was diagnosed as prostate cancer, with a Gleason score of 7 or below; 4. Abdominal and pelvic CT, prostate MRI and other imaging examinations did not reveal that the tumor invaded the extraprostatic tissue, and no lymph node metastasis or distant metastasis was found; 5. Willing to accept telephone follow-up; 6. Voluntarily sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Combined with other malignant tumors that have not been cured; 2. Check for suspected metastatic prostate cancer; 3. Received neoadjuvant therapy.

Design outcomes

Primary

MeasureTime frame
5-year PSA free survival;5-year overall survival;5-year metastatic free survival;

Secondary

MeasureTime frame
Average daily usage of changing pads;quality of life score;International Index of Erectile Function (IIEF-5) Questionnaire;

Countries

China

Contacts

Public ContactGuo Jianming

Zhongshan Hospital, Fudan University

guo.jianming@zs-hospital.sh.cn+86 13681971306

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026